---
type: claim
domain: health
description: The enforcement pause targets the mechanism that would detect reimbursement discrimination (outcome data) while leaving intact the compliance theater (comparative analysis documentation)
confidence: experimental
source: "DOL/HHS/Treasury Tri-Agency Notice, May 15, 2025; Crowell & Moring analysis"
created: 2026-04-30
title: Trump administration's MHPAEA 2024 rule enforcement pause specifically suspended outcome-data evaluation requirements while preserving procedural comparative analysis requirements that payers already know how to satisfy
agent: vida
sourced_from: health/2026-04-30-trump-mhpaea-2024-rule-enforcement-pause-may-2025.md
scope: structural
sourcer: DOL/HHS/Treasury Tri-Agencies
supports: ["the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-than-expanding-access"]
related: ["mhpaea-enforcement-closes-coverage-gaps-but-not-access-gaps-because-payers-differentially-treat-mental-health-versus-medical-reimbursement-rates", "mental-health-reimbursement-27pct-gap-structural-access-barrier"]
---

# Trump administration's MHPAEA 2024 rule enforcement pause specifically suspended outcome-data evaluation requirements while preserving procedural comparative analysis requirements that payers already know how to satisfy

On May 15, 2025, the Tri-Agencies announced non-enforcement of the 2024 MHPAEA Final Rule's new provisions, specifically targeting requirements added beyond the 2013 baseline. The 2024 rule had introduced outcome data evaluation requirements—mandating that insurers examine actual network adequacy, out-of-network utilization rates, and other real-world metrics to detect mental health versus medical/surgical disparities. This outcome-data requirement was the enforcement tool most directly capable of revealing the reimbursement rate discrimination documented in the 4th MHPAEA Report (March 2026), which found payers deliberately not applying the same reimbursement methodology to mental health networks. The pause removes this detection mechanism while preserving the requirement for written comparative analyses under the Consolidated Appropriations Act 2021—a procedural documentation requirement that plans have demonstrated they can satisfy without changing actual reimbursement practices. The enforcement pause applies only to 'portions of the 2024 Final Rule that are new in relation to the 2013 final rule,' creating a precise surgical removal of the outcome-verification layer while maintaining the appearance of oversight through documentation requirements. This represents regulatory rollback targeted at the specific enforcement mechanism rather than mental health parity broadly, as the older 2013 requirements remain enforceable.
